HCA Healthcare, Inc. (NYSE:HCA) Stake Lifted by UMB Bank n.a.

UMB Bank n.a. raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 44.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,271 shares of the company’s stock after buying an additional 391 shares during the period. UMB Bank n.a.’s holdings in HCA Healthcare were worth $408,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in HCA. Atlantic Edge Private Wealth Management LLC bought a new stake in HCA Healthcare during the fourth quarter worth approximately $27,000. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $28,000. Finally, GPS Wealth Strategies Group LLC lifted its position in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

HCA stock traded up $2.80 during trading on Friday, hitting $395.59. 884,271 shares of the stock traded hands, compared to its average volume of 1,126,563. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $395.91. The stock has a market cap of $103.61 billion, a price-to-earnings ratio of 19.72, a P/E/G ratio of 1.39 and a beta of 1.68. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a 50 day simple moving average of $348.60 and a 200 day simple moving average of $332.96.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the previous year, the company earned $4.29 EPS. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. Equities analysts expect that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,844 shares of company stock valued at $3,185,932. 1.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Barclays increased their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Leerink Partners raised their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. UBS Group raised their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Wells Fargo & Company raised their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Four research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $356.17.

Check Out Our Latest Stock Report on HCA Healthcare

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.